MDPI and ACS Style
Turner, B.M.; Finkelman, B.S.; Hicks, D.G.; Numbereye, N.; Moisini, I.; Dhakal, A.; Skinner, K.; Sanders, M.A.G.; Wang, X.; Shayne, M.;
et al. The Rochester Modified Magee Algorithm (RoMMa): An Outcomes Based Strategy for Clinical Risk-Assessment and Risk-Stratification in ER Positive, HER2 Negative Breast Cancer Patients Being Considered for Oncotype DX® Testing. Cancers 2023, 15, 903.
https://doi.org/10.3390/cancers15030903
AMA Style
Turner BM, Finkelman BS, Hicks DG, Numbereye N, Moisini I, Dhakal A, Skinner K, Sanders MAG, Wang X, Shayne M,
et al. The Rochester Modified Magee Algorithm (RoMMa): An Outcomes Based Strategy for Clinical Risk-Assessment and Risk-Stratification in ER Positive, HER2 Negative Breast Cancer Patients Being Considered for Oncotype DX® Testing. Cancers. 2023; 15(3):903.
https://doi.org/10.3390/cancers15030903
Chicago/Turabian Style
Turner, Bradley M., Brian S. Finkelman, David G. Hicks, Numbere Numbereye, Ioana Moisini, Ajay Dhakal, Kristin Skinner, Mary Ann G. Sanders, Xi Wang, Michelle Shayne,
and et al. 2023. "The Rochester Modified Magee Algorithm (RoMMa): An Outcomes Based Strategy for Clinical Risk-Assessment and Risk-Stratification in ER Positive, HER2 Negative Breast Cancer Patients Being Considered for Oncotype DX® Testing" Cancers 15, no. 3: 903.
https://doi.org/10.3390/cancers15030903